InvestorsObserver
×
News Home

Is Celsion Corporation (CLSN) a Winner in the Biotechnology Industry?

Thursday, February 11, 2021 10:05 AM | InvestorsObserver Analysts

Mentioned in this article

Is Celsion Corporation (CLSN) a Winner in the Biotechnology Industry?

The 66 rating InvestorsObserver gives to Celsion Corporation (CLSN) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 78 percent of stocks in the Biotechnology industry, CLSN’s 66 overall rating means the stock scores better than 66 percent of all stocks.

Overall Score - 66
CLSN has an Overall Score of 66. Find out what this means to you and get the rest of the rankings on CLSN!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 66 means the stock is more attractive than 66 percent of stocks.

This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Celsion Corporation Stock Today?

Celsion Corporation (CLSN) stock is trading at $2.83 as of 9:58 AM on Thursday, Feb 11, an increase of $0.88, or 44.87% from the previous closing price of $1.95. The stock has traded between $2.56 and $3.48 so far today. Volume today is more active than usual. So far 42,653,017 shares have traded compared to average volume of 17,258,583 shares.

Click Here to get the full Stock Score Report on Celsion Corporation (CLSN) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App